Abstract | BACKGROUND: OBJECTIVE: METHODS: Literature review. RESULTS: Used alone, intravitreal corticosteroids may benefit disorders such as DME, RVO and uveitis compared with standard therapy or observation. Patients with AMD may benefit more from combination treatment with photodynamic therapy, intravitreal corticosteroid and intravitreal anti- VEGF injections. Intraoperative use of these agents may assist in visualization and manipulation of fine retinal structures. Sustained-release intraocular implants have been approved for severe posterior uveitis, and have shown benefits in ongoing CTs. CONCLUSION:
|
Authors | Daniel F Kiernan, William F Mieler |
Journal | Expert opinion on pharmacotherapy
(Expert Opin Pharmacother)
Vol. 10
Issue 15
Pg. 2511-25
(Oct 2009)
ISSN: 1744-7666 [Electronic] England |
PMID | 19761356
(Publication Type: Journal Article, Review)
|
Chemical References |
- Anti-Inflammatory Agents
- Drug Implants
- Glucocorticoids
- Triamcinolone Acetonide
|
Topics |
- Animals
- Anti-Inflammatory Agents
(administration & dosage, adverse effects, therapeutic use)
- Clinical Trials as Topic
- Drug Implants
- Glucocorticoids
(administration & dosage, adverse effects, therapeutic use)
- Humans
- Injections
- Macular Degeneration
(drug therapy)
- Retinal Vein Occlusion
(drug therapy)
- Triamcinolone Acetonide
(administration & dosage, adverse effects, therapeutic use)
- Uveitis
(drug therapy)
- Vitreous Body
(metabolism)
|